There are some very good hearing aids on the market these days - although they still don't compensate for confirmation bias very well...
- Forums
- ASX - By Stock
- RCE
- Ann: Regulatory Approval for Registrational Phase 3 R327G Trial
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.08%
!
31.5¢

Ann: Regulatory Approval for Registrational Phase 3 R327G Trial, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $93.72M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 31.5¢ | $15.85K | 48.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2148 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 35483 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2605 | 0.315 |
3 | 32411 | 0.310 |
3 | 52528 | 0.305 |
6 | 30941 | 0.300 |
1 | 5000 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 34960 | 2 |
0.325 | 523 | 1 |
0.330 | 523 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
Last trade - 10.41am 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online